Literature DB >> 27116973

Ocular syphilis: opportunities to address important unanswered questions.

Susan Tuddenham1, Khalil G Ghanem1.   

Abstract

Entities:  

Keywords:  EPIDEMIOLOGY (GENERAL); OCULO-GENITAL INFECTION; SYPHILIS

Mesh：

Year:  2016        PMID： 27116973      PMCID： PMC5554954          DOI： 10.1136/sextrans-2016-052570

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN： 1368-4973            Impact factor:   3.519


× No keyword cloud information.
  27 in total

1.  Not so slowly progressive visual loss.

Authors:  H Danesh-Meyer; K C Kubis; R C Sergott
Journal:  Surv Ophthalmol       Date:  1999 Nov-Dec       Impact factor: 6.048

Review 2.  Syphilitic uveitis: a review of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virus-positive and negative patients.

Authors:  Bhagya Chathri Amaratunge; Jayne E Camuglia; Anthony J Hall
Journal:  Clin Exp Ophthalmol       Date:  2010-01       Impact factor: 4.207

3.  Ocular syphilis 1986. Prevalence of FTA-ABS reactivity and cerebrospinal fluid findings.

Authors:  T C Spoor; J M Ramocki; F A Nesi; M Sorscher
Journal:  J Clin Neuroophthalmol       Date:  1987-12

4.  Ocular syphilis. Acute and chronic.

Authors:  T C Spoor; P Wynn; W C Hartel; C S Bryan
Journal:  J Clin Neuroophthalmol       Date:  1983-09

5.  British Ocular Syphilis Study (BOSS): 2-year national surveillance study of intraocular inflammation secondary to ocular syphilis.

Authors:  Rashmi G Mathew; Beng T Goh; Mark C Westcott
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-12       Impact factor: 4.799

6.  Ocular syphilis among HIV-infected individuals.

Authors:  Jonathan Z Li; Joseph D Tucker; Ann-Marie Lobo; Christina M Marra; Benjamin T Davis; George N Papaliodis; Donna Felsenstein; Marlene L Durand; Sigal Yawetz; Gregory K Robbins
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

7.  Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy.

Authors:  Gayle P Balba; Princy N Kumar; Andrea N James; Anurag Malani; Allan G Palestine; James N Welch; Joseph G Timpone
Journal:  Am J Med       Date:  2006-05       Impact factor: 4.965

8.  Syphilitic episcleritis and scleritis.

Authors:  K R Wilhelmus; C M Yokoyama
Journal:  Am J Ophthalmol       Date:  1987-12-15       Impact factor: 5.258

Review 9.  Ocular syphilis.

Authors:  C E Margo; L M Hamed
Journal:  Surv Ophthalmol       Date:  1992 Nov-Dec       Impact factor: 6.048

10.  Syphilitic uveitis in patients infected with human immunodeficiency virus.

Authors:  Thi Ha Chau Tran; Nathalie Cassoux; Bahram Bodaghi; Christine Fardeau; Eric Caumes; Phuc Lehoang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-15       Impact factor: 3.535
View more
  4 in total

1.  Association between eye diagnosis and positive syphilis test results in a large, urban sexually transmitted infection/primary care clinic population.

Authors:  Ann-Marie Lobo; Yan Gao; Laura Rusie; Magda Houlberg; Supriya D Mehta
Journal:  Int J STD AIDS       Date:  2017-08-18       Impact factor: 1.359

2.  Neuroretinitis Syphilis in Human Immunodeficiency Virus-Infected Patient.

Authors:  Aa Mas Putrawati Triningrat; Ni Made Wasiastiti Budi; Igam Juliari; Ni Made Ayu Surasmiati; Siska Siska; Iga Ratna Suryaningrum
Journal:  Open Access Maced J Med Sci       Date:  2019-06-25

Review 3.  Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections.

Authors:  Sixto M Leal; Kyle G Rodino; W Craig Fowler; Peter H Gilligan
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

4.  Clinical Manifestations and Ophthalmic Outcomes of Ocular Syphilis at a Time of Re-Emergence of the Systemic Infection.

Authors:  João M Furtado; Tiago E Arantes; Heloisa Nascimento; Daniel V Vasconcelos-Santos; Natalia Nogueira; Rafael de Pinho Queiroz; Luana P Brandão; Thaís Bastos; Ricardo Martinelli; Rodrigo C Santana; Cristina Muccioli; Rubens Belfort; Justine R Smith
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.